These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 11536148

  • 1. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE, Patel A, Boyd P, James DC.
    Biotechnol Bioeng; 2001 Oct 20; 75(2):239-51. PubMed ID: 11536148
    [Abstract] [Full Text] [Related]

  • 2. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
    Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC.
    Biotechnol Bioeng; 2001 May 05; 73(3):188-202. PubMed ID: 11257601
    [Abstract] [Full Text] [Related]

  • 3. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J, Zheng YZ, James DC.
    Biotechnol Prog; 2005 May 05; 21(6):1644-52. PubMed ID: 16321047
    [Abstract] [Full Text] [Related]

  • 4. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ.
    Biochemistry; 2001 Jul 31; 40(30):8868-76. PubMed ID: 11467948
    [Abstract] [Full Text] [Related]

  • 5. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M, Hashii N, Tsukimura W, Osumi K, Harazono A, Tada M, Kiyoshi M, Matsuda A, Ishii-Watabe A.
    MAbs; 2019 Jul 31; 11(5):826-836. PubMed ID: 30990348
    [Abstract] [Full Text] [Related]

  • 6. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
    Gawlitzek M, Ryll T, Lofgren J, Sliwkowski MB.
    Biotechnol Bioeng; 2000 Jun 20; 68(6):637-46. PubMed ID: 10799988
    [Abstract] [Full Text] [Related]

  • 7. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics.
    Raju TS, Briggs JB, Borge SM, Jones AJ.
    Glycobiology; 2000 May 20; 10(5):477-86. PubMed ID: 10764836
    [Abstract] [Full Text] [Related]

  • 8. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M, Schlothauer T, Dashivets T, Malik S, Avenal C, Bulau P, Rüger P, Reusch D.
    PLoS One; 2015 May 20; 10(8):e0134949. PubMed ID: 26266936
    [Abstract] [Full Text] [Related]

  • 9. An investigation of intracellular glycosylation activities in CHO cells: effects of nucleotide sugar precursor feeding.
    Wong NS, Wati L, Nissom PM, Feng HT, Lee MM, Yap MG.
    Biotechnol Bioeng; 2010 Oct 01; 107(2):321-36. PubMed ID: 20506284
    [Abstract] [Full Text] [Related]

  • 10. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
    Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, Rudd PM, Woof JM, Dwek RA.
    J Biol Chem; 1998 Jan 23; 273(4):2260-72. PubMed ID: 9442070
    [Abstract] [Full Text] [Related]

  • 11. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A, Shanmugam D, Gadgil M.
    Metab Eng; 2022 Nov 23; 74():61-71. PubMed ID: 36152932
    [Abstract] [Full Text] [Related]

  • 12. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK, James DC.
    Biotechnol Bioeng; 2013 Nov 23; 110(11):2970-83. PubMed ID: 23737295
    [Abstract] [Full Text] [Related]

  • 13. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T, Thomann M, Rueger P, Knaupp A, Buchner J, Schlothauer T.
    PLoS One; 2015 Nov 23; 10(12):e0143520. PubMed ID: 26657484
    [Abstract] [Full Text] [Related]

  • 14. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions.
    Wang Q, Wang T, Zhang R, Yang S, McFarland KS, Chung CY, Jia H, Wang LX, Cipollo JF, Betenbaugh MJ.
    Biotechnol Bioeng; 2022 Jan 23; 119(1):102-117. PubMed ID: 34647616
    [Abstract] [Full Text] [Related]

  • 15. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
    Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, Flynn GC.
    Glycobiology; 2011 Jul 23; 21(7):949-59. PubMed ID: 21421994
    [Abstract] [Full Text] [Related]

  • 16. Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line.
    Kim J, Luo H, White W, Rees W, Venkat R, Albarghouthi M.
    MAbs; 2020 Jul 23; 12(1):1844928. PubMed ID: 33171078
    [Abstract] [Full Text] [Related]

  • 17. Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC.
    Raju TS.
    Methods Mol Biol; 2013 Jul 23; 988():169-80. PubMed ID: 23475719
    [Abstract] [Full Text] [Related]

  • 18. Strategic feeding of NS0 and CHO cell cultures to control glycan profiles and immunogenic epitopes of monoclonal antibodies.
    Villacrés C, Tayi VS, Butler M.
    J Biotechnol; 2021 Jun 10; 333():49-62. PubMed ID: 33901620
    [Abstract] [Full Text] [Related]

  • 19. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y, Jimenez Del Val I, Müller C, Wagtberg Sen J, Rasmussen SK, Kontoravdi C, Weilguny D, Andersen MR.
    Biotechnol Bioeng; 2015 Mar 10; 112(3):521-35. PubMed ID: 25220616
    [Abstract] [Full Text] [Related]

  • 20. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors.
    Blundell PA, Le NPL, Allen J, Watanabe Y, Pleass RJ.
    J Biol Chem; 2017 Aug 04; 292(31):12994-13007. PubMed ID: 28620050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.